Leaderboard

En | De
Sie sind hier: Gastroenterologie » Magen-Darm » Neoplasie 27. Oktober 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Diarrhoe
Entzündliche Darmerkrankungen
Funktionelle Beschwerden
Gastroenteritis
Gastrointestinale Hämorrhagie
Neoplasie
Peptische Ulzera
Anderes
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 12326  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 246518  
   
Hereditary Diffuse Gastric Cancer Syndrome.
Gastroenterol Clin North Am
Lerner BA, Llor X.
PMID: 42933935 [PubMed - indexed for MEDLINE]


Hamartomatous, Serrated, and Mixed Polyposis Syndromes.
Gastroenterol Clin North Am
Ebrahimzadeh JE, Zelley K, MacFarland SP, Katona BW.
PMID: 42933934 [PubMed - indexed for MEDLINE]


Updates in the Molecular Biology and Personalized Management of Lynch Syndrome.
Gastroenterol Clin North Am
Lee DJ, Yurgelun MB.
PMID: 42933932 [PubMed - indexed for MEDLINE]


A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study.
Eur J Cancer
Padilla CS, Bergerot CD, Bekta, Celik E, Robinson D, Bao Q, Burgers JA, Dejaco D, Fox L, Marquina G, Milanetto AC, Itkin B, Kindy AA, Lok C, di Monale E Bastia MB, Eichler M, Sodergren SC, Brouwer O, Ter Laan M, Tesselaar MET, van der Graaf WTA, Husson O, EORTC QoL Rare Cancer Study, EORTC Quality of Life Group.
PMID: 42933087 [PubMed - as supplied by publisher]


Identification of ceruloplasmin-binding anticancer peptides linked to cancer cell reprogramming in colorectal cancer.
Comput Biol Chem
Rehman A, Li T, Shaikh AL, Hassan SSU, Pan J.
PMID: 42933065 [PubMed - as supplied by publisher]


Survival modeling and assessing prognostic factors of colorectal cancer in Ethiopia: Addressing violation of statistical assumptions.
PLoS One
Abraha TG, Terefe MR, Asfaw ZG.
PMID: 42932349 [PubMed - indexed for MEDLINE]


Claudin-18 expression is associated with poorer overall survival in colorectal cancer.
PLoS One
Al-Kabariti AY, Abbas MA, Alashhab M, Smarakan S, Sughayer MA.
PMID: 42932274 [PubMed - indexed for MEDLINE]


Gut microbiome in colorectal cancer: a dual regulator of tumor biology and therapeutic response.
Folia Microbiol (Praha)
Chawda D, Tyagi N, Mubashra, Srivastava A, Shukla A, Srivastava S.
PMID: 42932086 [PubMed - as supplied by publisher]


Signal Mining of Adverse Events of Antiangiogenic Drugs in Colorectal Cancer Based on the FDA Adverse Event Reporting System (FAERS) Database.
J Gastrointest Cancer
Wu BX, Yu XN, Wu HT, Liu J.
PMID: 42932028 [PubMed - indexed for MEDLINE]


SLC25A39: A key regulator of mitochondrial metabolism and a promising therapeutic target in cancer.
Med Oncol
Tian T, Jin Y, Cui P, Lan S.
PMID: 42931978 [PubMed - indexed for MEDLINE]


Timing of diverting ileostomy closure after low anterior resection for rectal cancer: a GRADE-assessed systematic review and meta-analysis of early and delayed closure.
Langenbecks Arch Surg
Mirza W, Ullah SE, Babar M, Nand R, Hiraj UM, Soomro I, Saeed F, Ali RN.
PMID: 42931879 [PubMed - indexed for MEDLINE]


FGFR2b as a Therapeutic Biomarker in Gastric Cancer: Lessons from Bemarituzumab and Implications for Next-Generation Targeted Therapy.
Curr Oncol Rep
Sagawa T, Hirakawa M, Nagashima H, Fujikawa K.
PMID: 42931855 [PubMed - indexed for MEDLINE]


Cancer-associated fibroblasts and immune evasion in endometrial cancer: current evidence and therapeutic perspectives.
Med Oncol
Zhan J, Yan Z, Cao Z, Wu F, Wang Y, Zhan Y.
PMID: 42931843 [PubMed - indexed for MEDLINE]


Cancer Screening, Diagnosis, and Survival in California Prisons.
JAMA Netw Open
Manz CR, Tramontano AC, Voligny E, Dias SL, Dahlstrom M, Dunlap J, Johnson A, Rathore VD, Selby M, Sun RKP, Wright AA, Bick J.
PMID: 42931773 [PubMed - indexed for MEDLINE]


The Chemo-Gut Probiotic Trial Protocol: A Double-Blind Randomized Controlled Trial Investigating the Effects of a Multi-Strain Probiotic on Gut Microbiota, Gastrointestinal Symptoms, and Psychosocial Health Among Cancer Survivors.
Methods Protoc
Deleemans JM, Mina R, Spiropoulos A, Lawal OA, Reimer RA, Karim S, Richardson B, Carlson LE.
PMID: 42931362 [PubMed]


Advanced MR Technique for the Prediction of a Complete Response Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Comparative Study Between DWI b2000 and b1000.
J Pers Med
Lee G, Kim SH, Kim M, Kim D, Kim HR.
PMID: 42930811 [PubMed]


VEGF-A Immunohistochemical Expression Across Appendiceal Epithelial Lesions: A Retrospective Exploratory Study.
Med Sci (Basel)
Tavra A, , , Lozi, Ogorevc M, Krstulovi, Hrgovi, Kre, Bar.
PMID: 42930603 [PubMed - indexed for MEDLINE]


Association Between Low Anterior Resection Syndrome and Lower Urinary Tract Symptom Severity After Restorative Rectal Cancer Surgery.
Med Sci (Basel)
Lunca S, Morarasu S, Roata CE, Dimofte GM.
PMID: 42930601 [PubMed - indexed for MEDLINE]


From Dysbiosis to Symbiosis: Using the Gut Microbiome to Improve Cancer Outcomes.
Med Sci (Basel)
Nassar SA.
PMID: 42930589 [PubMed - indexed for MEDLINE]


Comparative Progression of Precancerous Gastric Lesions in Autoimmune and Helicobacter pylori-Associated Gastritis: A Longitudinal Cohort from Eastern Europe.
Med Sci (Basel)
Filip AM, Munteanu SN, Mocan S, Chiciudean PL, Arjoca L, Pantea CM, Filip MI, Negovan A.
PMID: 42930580 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 246518    Seite 1 von 12326  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1